Cargando…
Downregulation of TFPI in breast cancer cells induces tyrosine phosphorylation signaling and increases metastatic growth by stimulating cell motility
BACKGROUND: Increased hemostatic activity is common in many cancer types and often causes additional complications and even death. Circumstantial evidence suggests that tissue factor pathway inhibitor-1 (TFPI) plays a role in cancer development. We recently reported that downregulation of TFPI inhib...
Autores principales: | Stavik, Benedicte, Skretting, Grethe, Aasheim, Hans-Christian, Tinholt, Mari, Zernichow, Lillian, Sletten, Marit, Sandset, Per Morten, Iversen, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175223/ https://www.ncbi.nlm.nih.gov/pubmed/21849050 http://dx.doi.org/10.1186/1471-2407-11-357 |
Ejemplares similares
-
TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity
por: Stavik, Benedicte, et al.
Publicado: (2013) -
Indirect regulation of TFPI-2 expression by miR-494 in breast cancer cells
por: Andresen, Marianne S., et al.
Publicado: (2020) -
Syndecan-3 and TFPI Colocalize on the Surface of Endothelial-, Smooth Muscle-, and Cancer Cells
por: Tinholt, Mari, et al.
Publicado: (2015) -
TFPI Alpha and Beta Regulate mRNAs and microRNAs Involved in Cancer Biology and in the Immune System in Breast Cancer Cells
por: Stavik, Benedicte, et al.
Publicado: (2012) -
Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5’-Flanking Region
por: Ali, Huda Omar, et al.
Publicado: (2016)